Gensight Biologics SA
PAR:SIGHT
Gensight Biologics SA
PAR:SIGHT
Price:
0.0793
EUR
-4.46%
Market Closed
Market Cap:
€15.1m
Relative Value
The Relative Value of one
SIGHT
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 0.0793 EUR,
Gensight Biologics SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SIGHT Relative Value
HIDDEN
Multiples Across Competitors
SIGHT Competitors Multiples
Gensight Biologics SA Competitors
Gensight Biologics SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
Gensight Biologics SA
PAR:SIGHT
|
15.1m EUR | 77.9 | -1 | -1.4 | -1.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
394.1B USD | 6.6 | 167.9 | 16.3 | 23.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.3B USD | 5.5 | 26.4 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
188.3B USD | 6.5 | 23.2 | 15.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
119.5B USD | 10.2 | 32.5 | 23.9 | 24.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.8B USD | 5.7 | 18.1 | 15.4 | 17.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
89.1B AUD | 4 | 20.6 | 13.7 | 17.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.4B EUR | 14.1 | 33 | 56.3 | 57.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
